RISK

Trading carries substantial risk of loss. Prop evaluation fees are typically non-refundable and the majority of traders do not pass first attempts. This comparison is for informational purposes only and does not constitute financial advice. Read full risk warning

HEAD-TO-HEAD COMPARISON · 2026

Fuze Traders vs MyFundedFX

Side-by-side comparison of trust scores, profit splits, payout speed, and real trader reviews. Independent data — no sponsored rankings.

FUZE

Fuze Traders

MYFX

MyFundedFX

FUZE TRADERS

METRIC

MYFUNDEDFX

0/100TIE

TRUST SCORE

TIE0/100

0/5TIE

RATING

TIE0/5

—

PROFIT SPLIT

—

MAX FUNDING

—

MIN COST

—

PAYOUT DAYS

—

PASS RATE

—

0TIE

REVIEW COUNT

TIE0

FUZE TRADERS DETAILS

STEPS: -phase

MYFUNDEDFX DETAILS

STEPS: -phase

Fuze Traders PROS

+A listing exists for this firm, indicating some level of industry recognition.
+No confirmed below-average financial metrics are currently on record.
+The firm's tag is registered, suggesting an intent to participate in transparent comparison.
+Absence of restrictive data means no confirmed unfavorable terms are documented.

Fuze Traders CONS

−No data whatsoever is available for this firm, making objective evaluation impossible.
−Traders cannot compare any metrics to industry averages due to complete absence of information.
−Lack of founding date, country, and trading terms represents a significant transparency concern.

MyFundedFX PROS

+Country of operation is listed as Saint Vincent and the Grenadines, a known offshore financial jurisdiction.
+A registered tag suggests some formal industry presence.
+No confirmed below-average financial metrics are currently on record.
+Listing on a comparison platform indicates an intent toward transparency.

MyFundedFX CONS

−No trading or financial metrics are available to evaluate this firm objectively.
−Without data on profit split, funding, or costs, no comparison to industry averages is possible.
−Traders cannot assess payout speed, drawdown rules, or profit targets from available data.

PROPDNA VERDICT